Attachment
Gates Package, p.65 · gates:exh:00031
Page text: p.65 · original PDF
- Date
- — (unknown precision)
- Type
- attachment · document
- Topics
- Therapeutics and treatments
evaluation and other usages.
e
Anticipated December 2014
o
Biocryst will make available an additional 10 treatment courses for clinical evaluation
and other usages.
o
Biocryst will file an IND with the FDA to conduct a Phase 1 clinical trial.
e
January 2015 -- Biocryst will initiate enrollment into a Phase 1 clinical trial for safety.
Medivector -- Favipiravir antiviral drug